enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Athersys Jumps More Than 20% After FDA Approves ... - AOL

    www.aol.com/news/athersys-jumps-more-20-fda...

    Shares in Athersys, Inc. (ATHX) soared more than 20% in U.S. premarket trading after the biotech company announced that it was granted approval by the Food and Drug Administration (FDA) to start a ...

  3. Athersys, Inc. (ATHX) Upgraded to Buy: Here's Why - AOL

    www.aol.com/news/athersys-inc-athx-upgraded-buy...

    Athersys, Inc. (ATHX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  4. Athersys (ATHX) Upgraded to Strong Buy: Here's What You ...

    www.aol.com/news/athersys-athx-upgraded-strong...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Implied Volatility Surging for Athersys (ATHX) Stock Options

    www.aol.com/news/implied-volatility-surging...

    For premium support please call: 800-290-4726 more ways to reach us

  6. For premium support please call: 800-290-4726 more ways to reach us

  7. Are Options Traders Betting on a Big Move in Athersys (ATHX ...

    www.aol.com/news/options-traders-betting-big...

    For premium support please call: 800-290-4726 more ways to reach us

  8. Are Institutions Heavily Invested In Athersys, Inc.'s (NASDAQ ...

    www.aol.com/news/institutions-heavily-invested...

    Every investor in Athersys, Inc. ( NASDAQ:ATHX ) should be aware of the most powerful shareholder groups. Insiders... Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...

  9. Athersys (ATHX) Down as Ischemic Stroke Study Fails to ... - AOL

    www.aol.com/news/athersys-athx-down-ischemic...

    While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.